Healthcare provider profile · identity verified

Patrick K. Lenz, MD

Family Practice · CRESSON, PA · NPI 1639178437

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	645	179
Pantoprazole Sodium	Pantoprazole Sodium	427	107
Amlodipine Besylate	Amlodipine Besylate	401	109
Levothyroxine Sodium	Levothyroxine Sodium	312	79
Lisinopril	Lisinopril	293	82
Potassium Chloride	Potassium Chloride	275	54
Rosuvastatin Calcium	Rosuvastatin Calcium	275	79
Tamsulosin Hcl	Tamsulosin Hcl	272	58
Metformin Hcl	Metformin Hcl	250	70
Omeprazole	Omeprazole	230	55
Eliquis	Apixaban	224	42
Metoprolol Succinate	Metoprolol Succinate	223	53
Gabapentin	Gabapentin	213	44
Oxycodone Hcl	Oxycodone Hcl	194	25
Furosemide	Furosemide	186	43
Losartan Potassium	Losartan Potassium	182	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	178	27
Metoprolol Tartrate	Metoprolol Tartrate	178	42
Alprazolam	Alprazolam	170	43
Simvastatin	Simvastatin	166	46
Lorazepam	Lorazepam	131	41
Montelukast Sodium	Montelukast Sodium	129	26
Hydrochlorothiazide	Hydrochlorothiazide	128	32
Famotidine	Famotidine	126	23
Jardiance	Empagliflozin	126	26
Metformin Hcl Er	Metformin Hcl	123	32
Allopurinol	Allopurinol	119	30
Albuterol Sulfate Hfa	Albuterol Sulfate	116	46
Clopidogrel	Clopidogrel Bisulfate	107	25
Glimepiride	Glimepiride	107	30
Tramadol Hcl	Tramadol Hcl	107	29
Escitalopram Oxalate	Escitalopram Oxalate	97	30
Meloxicam	Meloxicam	97	27
Tizanidine Hcl	Tizanidine Hcl	97	24
Trazodone Hcl	Trazodone Hcl	96	16
Carvedilol	Carvedilol	95	16
Synthroid	Levothyroxine Sodium	92	22
Ozempic	Semaglutide	90	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	28
Ezetimibe	Ezetimibe	88	25
Warfarin Sodium	Warfarin Sodium	83	13
Zolpidem Tartrate	Zolpidem Tartrate	81	20
Duloxetine Hcl	Duloxetine Hcl	80	21
Fluticasone Propionate	Fluticasone Propionate	77	25
Pravastatin Sodium	Pravastatin Sodium	75	20
Citalopram Hbr	Citalopram Hydrobromide	72	21
Clonazepam	Clonazepam	67	15
Venlafaxine Hcl Er	Venlafaxine Hcl	66	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	65	16
Olmesartan Medoxomil	Olmesartan Medoxomil	64	19
Sertraline Hcl	Sertraline Hcl	64	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	16
Spironolactone	Spironolactone	61	15
Prednisone	Prednisone	58	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	22
Baclofen	Baclofen	56	12
Morphine Sulfate Er	Morphine Sulfate	56	suppressed
Buspirone Hcl	Buspirone Hcl	51	15
Finasteride	Finasteride	49	11
Donepezil Hcl	Donepezil Hcl	48	13
Terazosin Hcl	Terazosin Hcl	48	14
Doxycycline Hyclate	Doxycycline Hyclate	47	40
Amitriptyline Hcl	Amitriptyline Hcl	46	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	46	13
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Atenolol	Atenolol	42	13
Esomeprazole Magnesium	Esomeprazole Magnesium	41	suppressed
Olanzapine	Olanzapine	41	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	11
Topiramate	Topiramate	38	suppressed
Celecoxib	Celecoxib	37	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	12
Azithromycin	Azithromycin	35	34
Januvia	Sitagliptin Phosphate	35	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Xarelto	Rivaroxaban	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	12
Bupropion Xl	Bupropion Hcl	33	suppressed
Amoxicillin	Amoxicillin	32	26
Cephalexin	Cephalexin	32	27
Pregabalin	Pregabalin	32	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	32	28
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Fentanyl	Fentanyl	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Primidone	Primidone	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Dutasteride	Dutasteride	28	suppressed
Entresto	Sacubitril/Valsartan	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	suppressed
Oxcarbazepine	Oxcarbazepine	26	suppressed
Oxycontin	Oxycodone Hcl	26	suppressed
Cefdinir	Cefdinir	23	22
Droplet Pen Needle	Pen Needle, Diabetic	23	suppressed
Fenofibrate	Fenofibrate,micronized	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Linzess	Linaclotide	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	15
Diazepam	Diazepam	21	suppressed
Levofloxacin	Levofloxacin	21	21
Nadolol	Nadolol	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Naproxen	Naproxen	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	19
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Temazepam	Temazepam	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Methylprednisolone	Methylprednisolone	16	14
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Rivastigmine	Rivastigmine Tartrate	15	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	14	14
Divalproex Sodium	Divalproex Sodium	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Fluconazole	Fluconazole	13	11
Lamotrigine	Lamotrigine	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Niacin Er	Niacin	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Percocet	Oxycodone Hcl/Acetaminophen	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Tiotropium Bromide	Tiotropium Bromide	13	suppressed
Trulance	Plecanatide	13	suppressed
Xtampza Er	Oxycodone Myristate	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Phenytoin	Phenytoin	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error